|
2023
|
Invention
|
Solabegron zwitterion and uses thereof.
This application relates to solabegron zwitterion useful... |
|
2022
|
Invention
|
Compositions of micronized solabegron and methods of use.
Disclosed herein are compositions and ... |
|
|
Invention
|
Compositions of micronized solabegron and methods of use. Disclosed herein are compositions and m... |
|
2020
|
Invention
|
Solabegron zwitterion and uses thereof. This application relates to solabegron zwitterion useful ... |
|
2019
|
Invention
|
Pharmaceutical compositions and the treatment of overactive bladder. The present invention relate... |
|
2018
|
Invention
|
Compositions and methods of using modified release solabegron for lower urinary tract symptoms. T... |
|
2013
|
Invention
|
Pharmaceutical combination. Pharmaceutical combinations comprising a beta-3 adrenergic receptor a... |
|
2011
|
Invention
|
Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for tre... |
|
|
Invention
|
Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antago... |
|
2008
|
Invention
|
Process of preparing arylethanoldiamines. An improved process for preparing arylethanoldiamines i... |
|
2003
|
Invention
|
Phenethanolamine derivatives, compositions, and their use as agonists at atypical beta-adrenorece... |
|
|
Invention
|
Process. An improved process for preparing arylethanoldiamines is described. Compounds of this ty... |
|
2002
|
Invention
|
Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabe... |
